Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients: The experience of the Italian Registry of Pediatric Chronic Dialysis

Enrico Vidal; Alberto Edefonti; Flora Puteo; Roberto Chimenz; Bruno Gianoglio; Giancarlo Lavoratti; Giovanna Leozappa; Silvio Maringhini; Francesca Mencarelli; Carmine Pecoraro; Ilse Maria Ratsch; Rossella Cannavò; Tommaso De Palo; Sara Testa; Luisa Murer; Enrico Verrina

doi:10.1093/ndt/gft061

Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients: The experience of the Italian Registry of Pediatric Chronic Dialysis

Enrico Vidal, Alberto Edefonti, Flora Puteo, Roberto Chimenz, Bruno Gianoglio, Giancarlo Lavoratti, Giovanna Leozappa, Silvio Maringhini, Francesca Mencarelli, Carmine Pecoraro, Ilse Maria Ratsch, Rossella Cannavò, Tommaso De Palo, Sara Testa, Luisa Murer, Enrico Verrina

Research output: Contribution to journal › Article › peer-review

Abstract

BackgroundPaediatric literature about encapsulating peritoneal sclerosis (EPS) is limited and comes primarily from anecdotic experiences. In this study, we described the incidence and characteristics of EPS in a large paediatric chronic peritoneal dialysis (CPD) patient population.MethodsWe reviewed files of patients starting CPD at 12 months of age from the same registry (1:28.3 CPD-months). The mortality rate was 43%. A more aggressive course and an association with calcineurin inhibitors were observed in transplanted patients. ConclusionsSurveillance for EPS should be maintained in high-risk children who received long-term PD even after years from CPD withdrawal.

Original language	English
Pages (from-to)	1603-1609
Number of pages	7
Journal	Nephrology Dialysis Transplantation
Volume	28
Issue number	6
DOIs	https://doi.org/10.1093/ndt/gft061
Publication status	Published - Jun 2013

Keywords

Children
Encapsulating peritoneal sclerosis
Peritoneal dialysis

ASJC Scopus subject areas

Nephrology
Transplantation

Access to Document

10.1093/ndt/gft061

Cite this

Vidal, E., Edefonti, A., Puteo, F., Chimenz, R., Gianoglio, B., Lavoratti, G., Leozappa, G., Maringhini, S., Mencarelli, F., Pecoraro, C., Ratsch, I. M., Cannavò, R., De Palo, T., Testa, S., Murer, L., & Verrina, E. (2013). Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients: The experience of the Italian Registry of Pediatric Chronic Dialysis. Nephrology Dialysis Transplantation, 28(6), 1603-1609. https://doi.org/10.1093/ndt/gft061

Vidal, E, Edefonti, A, Puteo, F, Chimenz, R, Gianoglio, B, Lavoratti, G, Leozappa, G, Maringhini, S, Mencarelli, F, Pecoraro, C, Ratsch, IM, Cannavò, R, De Palo, T, Testa, S, Murer, L & Verrina, E 2013, 'Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients: The experience of the Italian Registry of Pediatric Chronic Dialysis', Nephrology Dialysis Transplantation, vol. 28, no. 6, pp. 1603-1609. https://doi.org/10.1093/ndt/gft061

@article{df3485d8a3184a6d9e56af982416cbf3,

title = "Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients: The experience of the Italian Registry of Pediatric Chronic Dialysis",

abstract = "BackgroundPaediatric literature about encapsulating peritoneal sclerosis (EPS) is limited and comes primarily from anecdotic experiences. In this study, we described the incidence and characteristics of EPS in a large paediatric chronic peritoneal dialysis (CPD) patient population.MethodsWe reviewed files of patients starting CPD at 12 months of age from the same registry (1:28.3 CPD-months). The mortality rate was 43%. A more aggressive course and an association with calcineurin inhibitors were observed in transplanted patients. ConclusionsSurveillance for EPS should be maintained in high-risk children who received long-term PD even after years from CPD withdrawal.",

keywords = "Children, Encapsulating peritoneal sclerosis, Peritoneal dialysis",

author = "Enrico Vidal and Alberto Edefonti and Flora Puteo and Roberto Chimenz and Bruno Gianoglio and Giancarlo Lavoratti and Giovanna Leozappa and Silvio Maringhini and Francesca Mencarelli and Carmine Pecoraro and Ratsch, {Ilse Maria} and Rossella Cannav{\`o} and {De Palo}, Tommaso and Sara Testa and Luisa Murer and Enrico Verrina",

year = "2013",

month = jun,

doi = "10.1093/ndt/gft061",

language = "English",

volume = "28",

pages = "1603--1609",

journal = "Nephrology Dialysis Transplantation",

issn = "0931-0509",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients

T2 - The experience of the Italian Registry of Pediatric Chronic Dialysis

AU - Vidal, Enrico

AU - Edefonti, Alberto

AU - Puteo, Flora

AU - Chimenz, Roberto

AU - Gianoglio, Bruno

AU - Lavoratti, Giancarlo

AU - Leozappa, Giovanna

AU - Maringhini, Silvio

AU - Mencarelli, Francesca

AU - Pecoraro, Carmine

AU - Ratsch, Ilse Maria

AU - Cannavò, Rossella

AU - De Palo, Tommaso

AU - Testa, Sara

AU - Murer, Luisa

AU - Verrina, Enrico

PY - 2013/6

Y1 - 2013/6

N2 - BackgroundPaediatric literature about encapsulating peritoneal sclerosis (EPS) is limited and comes primarily from anecdotic experiences. In this study, we described the incidence and characteristics of EPS in a large paediatric chronic peritoneal dialysis (CPD) patient population.MethodsWe reviewed files of patients starting CPD at 12 months of age from the same registry (1:28.3 CPD-months). The mortality rate was 43%. A more aggressive course and an association with calcineurin inhibitors were observed in transplanted patients. ConclusionsSurveillance for EPS should be maintained in high-risk children who received long-term PD even after years from CPD withdrawal.

AB - BackgroundPaediatric literature about encapsulating peritoneal sclerosis (EPS) is limited and comes primarily from anecdotic experiences. In this study, we described the incidence and characteristics of EPS in a large paediatric chronic peritoneal dialysis (CPD) patient population.MethodsWe reviewed files of patients starting CPD at 12 months of age from the same registry (1:28.3 CPD-months). The mortality rate was 43%. A more aggressive course and an association with calcineurin inhibitors were observed in transplanted patients. ConclusionsSurveillance for EPS should be maintained in high-risk children who received long-term PD even after years from CPD withdrawal.

KW - Children

KW - Encapsulating peritoneal sclerosis

KW - Peritoneal dialysis

UR - http://www.scopus.com/inward/record.url?scp=84879862161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879862161&partnerID=8YFLogxK

U2 - 10.1093/ndt/gft061

DO - 10.1093/ndt/gft061

M3 - Article

C2 - 23585587

AN - SCOPUS:84879862161

VL - 28

SP - 1603

EP - 1609

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 6

ER -

Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients: The experience of the Italian Registry of Pediatric Chronic Dialysis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this